XellSmart
PrivateLast Round
Series A
Extension
Apr 18, 2023
Total Funding Raised
$45.9M
Company Overview
XellSmart is a biotechnology company that develops clinical-grade, allogeneic, off-the-shelf, iPSC-derived cell therapies for central nervous system diseases such as Parkinson's and ALS.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
iPSC-derived cell therapyallogeneic cell therapyoff-the-shelf cell therapyinduced pluripotent stem cellsiPSCregenerative medicinestem cell therapyCNS disease treatmentneurodegenerative diseaseParkinson's disease treatmentspinal cord injury treatmentneural progenitor cellsclinical-stage biotechGMP manufacturingINDOrphan Drug Designation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
XellSmart Comps
Public and private peers based on sector, stage, and business model.
XellSmart Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Apr 18, 2023 | ||||
| Series A | Nov 8, 2022 | ||||
| Pre Seed | Sep 8, 2021 |
XellSmart Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Huatai Zijin Investment Co., Ltd. | Series A Extension |
| Fig | Series A |
| Tianjin TEDA Science and Technology Investment Co., Ltd. | Pre Seed |
| YuanBio Venture Capital | Pre Seed |
| Next Capital | Series A, Pre Seed |
| FreesFund | Series A, Pre Seed |
| Gold Mountains Asset Management | Series A Extension |
XellSmart Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersSuzhou
Employee Range3
Year Founded2021
Last FundingApr 18, 2023
